Skip to content

Elicio Therapeutics, Inc.

ELTX· NasdaqCore metricsCIK 1601485

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -2.79%
Market cap
$44.44M
28.31M shares
Filings
385
$0.00
Q1 2023−91.9% FY22 yoy
-$7.98M
Q3 2026N/M FY25 yoy
-$8.45M
Q3 2026N/M FY25 yoy
-$36.97M
FY 2025derivedN/M FY25 yoy
-$0.30
Q3 2026N/M FY25 yoy
$30.90M
Q3 2026+5.4% FY25 yoy
$44.44M
—
—
2.4×
-83.18%
—

FY2025 figures · derived

Price

$1.5782.99%$7.66past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$2.30MFY 2022
$28.31M0FY 2020FY 2021FY 2022
PeriodEndedValueKindSource trail
FY 20222022-12-31$2,301,000reported
FY 20212021-12-31$28,312,000reported
FY 20202020-12-31$2,880,000reported

Capital returns

Dividends and buybacks · FY2022 to FY2024
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2024—$0.00$0.00—15.95M sh+55.9%—
FY2023—$150.00K$150.00K—10.23M sh−66.0%—
FY2022—$0.00$0.00—30.11M sh+0.5%—

Pharmaceutical preparations

Elicio Therapeutics, Inc. is the 339th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Elicio Therapeutics, Inc. · CIK 1601485 · Engraved from SEC EDGAR